TY  - GEN
AU  - Raïch-Regué, Dalia
AU  - Tenorio, Raquel
AU  - Fernández de Castro, Isabel
AU  - Tarrés-Freixas, Ferran
AU  - Sachse, Martin
AU  - Perez-Zsolt, Daniel
AU  - Muñoz-Basagoiti, Jordana
AU  - Fernández-Sánchez, Sara Y
AU  - Gallemí, Marçal
AU  - Ortega-González, Paula
AU  - Fernández-Oliva, Alberto
AU  - Gabaldón, José A
AU  - Nuñez-Delicado, Estrella
AU  - Casas, Josefina
AU  - Roca, Núria
AU  - Cantero, Guillermo
AU  - Pérez, Mónica
AU  - Usai, Carla
AU  - Lorca-Oró, Cristina
AU  - Alert, Júlia-Vergara
AU  - Segalés, Joaquim
AU  - Carrillo, Jorge
AU  - Blanco, Julià
AU  - Clotet Sala, Bonaventura
AU  - Cerón-Carrasco, José P
AU  - Izquierdo-Useros, Nuria
AU  - Risco, Cristina
PY  - 2023
DO  - 10.1016/j.biopha.2023.114997
UR  - http://hdl.handle.net/20.500.12105/16824
AB  - The SARS-CoV-2 pandemic made evident that there are only a few drugs against coronavirus. Here we aimed to identify a cost-effective antiviral with broad spectrum activity and high safety profile. Starting from a list of 116 drug candidates, we used...
LA  - eng
PB  - Elsevier
KW  - Antiviral
KW  - COVID-19
KW  - Coronavirus
KW  - Cyclodextrin
KW  - Drug repurposing
KW  - SARS-CoV-2
KW  - β-cyclodextrin
KW  - COVID-19
KW  - beta-Cyclodextrins
KW  - Dermatologic Agents
KW  - Humans
KW  - SARS-CoV-2
KW  - Antiviral Agents
TI  - β-Cyclodextrins as affordable antivirals to treat coronavirus infection
TY  - research article
ER  -